SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, ...
Sometimes, an abnormal EKG reading is a normal variation in a person’s heart rhythm. In other cases, it may be due to an underlying heart condition or a reaction to medication. An electrocardiogram ...
Hosted on MSN
HeartBeam (NASDAQ: BEAT) secures FDA 510(k) clearance for 12-lead ECG synthesis software following successful appeal
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, received FDA 510(k) clearance for its 12-lead ECG synthesis software for ...
Since the Apple Watch Series 4 was announced in September, one of its most anticipated functions has been the promise to perform a mobile electrocardiogram (ECG or EKG) whenever a consumer wants. The ...
Introduction ECG in pre-participation screening in athletes is still debated. It is of relevant interest to have an automatic detection for this screening. 44’000 person a year are undergoing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results